Companion diagnostics hailed as pivotal for safety, but can personalised medicines deliver?
This article was originally published in Clinica
Executive Summary
Last month, the UK BioIndustry Association and the Medicines and Healthcare products Regulatory Agency held a meeting in London to discuss the evolving regulatory landscape of personalised medicine. Amanda Maxwell reports